Screening for coronary artery disease in asymptomatic patients with type 2 diabetes mellitus

Chinese Medical Journal

Volumn 120, Issue 21, 2007, Pages 1859-1861

  Shen, Wei Feng ^a  

^a SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

Coronary artery disease; Disease screening; Type 2 diabetes mellitus

Indexed keywords

CALCIUM; DOBUTAMINE; GLUCOSE; GLYCOSYLATED ALBUMIN; HEMOGLOBIN A1C; INSULIN;

ALBUMIN BLOOD LEVEL; ANGIOCARDIOGRAPHY; ATHEROSCLEROTIC PLAQUE; CALCIFICATION; CALCIUM METABOLISM; CARDIOVASCULAR RISK; COMPUTED TOMOGRAPHIC ANGIOGRAPHY; CORONARY ARTERY ATHEROSCLEROSIS; CORONARY ARTERY DISEASE; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DISEASE ASSOCIATION; EARLY DIAGNOSIS; EDITORIAL; ELECTRON BEAM TOMOGRAPHY; EXERCISE ELECTROCARDIOGRAPHY; EXERCISE TEST; GLUCOSE BLOOD LEVEL; HEART INFARCTION; HEART MUSCLE ISCHEMIA; HEART MUSCLE PERFUSION; HEART SCINTISCANNING; HEMOGLOBIN BLOOD LEVEL; HIGH RISK PATIENT; HUMAN; INCIDENCE; INSULIN TREATMENT; INTERMETHOD COMPARISON; MASS SCREENING; MORBIDITY; MORTALITY; NON INSULIN DEPENDENT DIABETES MELLITUS; NON INVASIVE MEASUREMENT; PHARMACOLOGIC STRESS TESTING; PREVALENCE; PROGNOSIS; RISK ASSESSMENT; SCREENING TEST; SENSITIVITY AND SPECIFICITY; SILENT MYOCARDIAL ISCHEMIA; STRESS ECHOCARDIOGRAPHY; SURVIVAL TIME; SYMPTOMATOLOGY;

EID: 36148973921     PISSN: 03666999     EISSN: None     Source Type: Journal    
DOI: 10.1097/00029330-200711010-00001     Document Type: Editorial

References (26)

1. Hu Dy, Pan CY, Yu JM for the China Heart Survey Group. The relationship between coronary artery disease and abnormal glucose regulation in China: the China Heart Survey. Eur Heart J 2006 27: 2573-2579.
2. Wu YF, Liu XQ, Li X, Li Y, Zhao LC, Chen Z, et al for the USA-PRC Collaborative Study of Cardiovascular and Cardiopulmonary Epidemiology Research Group and the China Multicenter Collaborative Study of Cardiovascular Epidemiology (China MUCA) Research Group. Estimation of 10-year risk of fatal and nonfatal ischemic cardiovascular diseases in Chinese adults. Circulation 2006 114: 2217-2225.
3. Zhang YQ, Zhang YN, Cui C, Fan Y, Chang ML, Yu WG, et al. The role of oral glucose tolerance test in screening for diabetes mellitus in the elderly of Harbin, China Chin Med J 2005; 118: 418-420.
4. Tenerz A, Lonnberg I, Berne C, Nilsson G, Leppert J. Myocardial infarction and prevalence of diabetes mellitus. Eur Heart J 2001; 22: 1102-1110.
5. Buse JB, Ginsberg HN, Bakris GL, Lark NG, Costa F, Eckel R, et al. Primary prevention of cardiovascular disease in people with diabetes mellitus. A scientific statement from the American Heart Association and the American Diabetes Association. Circulation 2007; 115: 114-126.
6. Di Carli MF, Hachamovitch R. Should we screen for occult coronary artery disease among asymptomatic patients with diabetes. J Am Coll Cardiol 2005; 45: 50-54.
7. Miller TD, Redberg RF, Wackers FJ. Screening asymptomatic diabetic patients for coronary artery disease. Why not? J Am Coll Cardiol 2006; 48: 761-764.
8. Beller GA. Noninvasive screening for coronary atherosclerosis and silent myocardial Ischemia in asymptomatic type 2 diabetic patients. Is it appropriate and cost-effective? J Am Coll Cardiol 2007; 49: 1918-1923.
9. Albers AR, Krichavsky MZ, Balady GJ. Stress testing in patients with diabetes mellitus. Diagnosis and prognostic value. Circulation 2006; 113; 583-592.
10. Hennessy TG, Codd MB, Kane G, McCarthy C, McCann HA, Sugrue DD. Evaluation of patients with diabetes mellitus for coronary artery disease using dobutamine stress echocardiography. Coron Artery Dis 1997; 8: 171-174.
11. Sozzi FB, Elhendy A, Roelandt JR, van Domburg RT, Schinkel AF, Vourvouri EC, et al. Prognostic value of dobutamine stress echocardiography in patients with diabetes. Diabetes Care 2003; 26: 1074-1078.
12. Wackers FL, Young LH, Inzucchi E, Chyun DA, Davey JA, Barrett EJ, et al for the Detection of Ischemia in Asymptomatic Diabetics (DIAD) Investigators. Detection of silent myocardial ischemia in asymptomatic diabetic subjects: the DIAD study. Diabetes Care 2004; 27: 1954-1961.
13. Pletcher MJ, Tice JA, Pignone M, Browner WS. Using the coronary artery calcium score to predict coronary heart disease events: a systematic review and meta-analysis. Arch Intern Med 2004; 164: 1266-1268.
14. Rage P, Shaw LJ, Berman DS, Callister TQ. Prognostic value of coronary artery calcium screening in subjects with and without diabetes. J Am Coll Cardiol 2004; 43: 1663-1669.
15. De Feyter PJ, van Pelt N. Spiral computed tomography coronary angiography. J Am Coll Cardiol 2007; 49: 872-874.
16. Hendel R, Patel M, Kramer C, Poon M. Appopriateness criteria for cardiac computed tomography and cardiac magnetic resonance imaging. J Am Coll Cardiol 2006; 48: 735-1097.
17. Redberg RF. Computed tomographic angiography. More than just a pretty picture? Am J Coll Cardiol 2007; 49: 1827-1829.
18. Gacia M, Lessick J, Hoffmann M. Accuracy of 16-row multidetector computed tomography for the assessment of coronary artery stenosis. JAMA 2006; 296: 403-414.
19. Coles DR, Smail MA, Negus IS, Wilde P, Oberhoff M, Karsch KR, et al. Comparison of radiation doses from multislice computed tomography and conventional diagnostic angiography. J Am Coll Cardiol 2006; 47: 1840-1845.
20. Ravipati G, Aronow WS, Ahn C, Sujate K, Saulle LN, Weiss WB. Association of hemoglobin Alc level with the severity of coronary artery disease in patients with diabetes mellitus. Am. J Cardiol 2006; 97: 968-969.
21. Rendell M, Paulsen R, Eastberg S, Stephen PM, Valentine JL, Smith CH, et al. Clinical use and time relationship of changes in Affinity measurement of glycosylated albumin and glycosylated hemoglobin. Am J Med Sci 1986; 292: 11-44.
22. Pu LJ, Lu L, Shen WF, Zhang Q, Zhang RY, Zhang JS, et al. Increase serum glycated albumin level is associated with the presence and severity of coronary artery disease in type 2 diabetic patients. Circ J 2007; 71: 1067-1073.
23. Lu L, Pu LJ, Xu XW, Zhang Q, Zhang RY, Zhang JS, et al. Association of serum levels of glycated albumin, C-reactive protein and tumor necrosis factor-alpha with the severity of coronary artery disease and renal impairment in patients with type 2 diabetes mellitus. Clin Biochem 2007; 40: 810-816
24. Stitt AW, Jenkins AJ, Cooper ME. Advanced glycation end products and diabetic complications. Expert Opin Investig. Drugs 2002; 11: 1205-1223.
25. Pu LJ, Lu L, Xu XW, Zhang RY, Zhang Q, Zhang JS, et al. Value of serum glycated albumin and high-sensitivity C-reactive protein levels in the prediction of presence of coronary artery disease in patients with type 2 diabetes. Cardiovasc Diabetol 2006; 20; 5: 27.
26. Zhang Q, Fang YH, Zhang RY, Hu J, Yang ZK, Ni J, et al. Drug-eluting stents improve clinical outcomes in Chinese diabetic patients with de novo coronary artery disease. Chin Med J 2006; 119: 1576-1579.